IB Delta Suite

Imaging Biometrics

Key Features

Delta T1 maps
Image standardization

General Information

Product name

IB Delta Suite

Company

Imaging Biometrics

Subspeciality

Neuro

Modality

Disease targeted

Neuro lesions

Main task

Not specified

Technical Specifications

Population

Neuro exams

Patient population age

Not specified

Input

T1-weighted, pre- and post-contrast images

Input format

DICOM

Output

Quantitative Delta T1 maps

Output format

DICOM (RGB and monochrome)

Integration

Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone third party application

Deployment

Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker)

Trigger for analysis

Automatically, Etc., Image upload, On demand, Right after the image acquisition, Triggered by a user through e.g. a button click

Processing time

< 3 sec

Regulatory Information

CE Certification

Pathway:

MDD

Class:

Class I

Verified by Health AI Register

FDA Certification

Pathway:

510(k) cleared

Class:

Class II

Verified by Health AI Register

Other certifications

Not specified

Market Presence

On market since

01-2013

AI Platforms

Bayer Pharmaceuticals, Blackford Analysis, Medimsight, TeraRecon

Resellers

Aycan medical systems, CorTechs Labs, Pixmeo, QMENTA

Countries present

Not specified

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

One-off payment with service contract, Subscription

Based on

Number of analyses, Number of installations, Number of users

Evidence & Research

Peer-Reviewed Papers

Peer-Reviewed

View

Quantitative Delta T1 (dT1) as a Replacement for Adjudicated Central Reader Analysis of Contrast-Enhancing Tumor Burden: A Subanalysis of the American College of Radiology Imaging Network 6677/Radiation Therapy Oncology Group 0625 Multicenter Brain Tumor Trial

Source: vendor | First published: Jul 31, 2020 | Last updated: Jul 9, 2025